国产外源性肺表面活性物质治疗新生儿重症感染性肺炎多中心前瞻性临床研究

邱如新, 刘欣, 王加莉, 蔡成, 曾军安, 刘汉楚, 程锐, 李占魁, 刘敬

中国当代儿科杂志 ›› 2019, Vol. 21 ›› Issue (4) : 327-331.

PDF(1394 KB)
HTML
PDF(1394 KB)
HTML
中国当代儿科杂志 ›› 2019, Vol. 21 ›› Issue (4) : 327-331. DOI: 10.7499/j.issn.1008-8830.2019.04.005
论著·临床研究

国产外源性肺表面活性物质治疗新生儿重症感染性肺炎多中心前瞻性临床研究

  • 邱如新1, 刘欣2, 王加莉3, 蔡成4, 曾军安5, 刘汉楚2, 程锐3, 李占魁5, 刘敬1
作者信息 +

Clinical effect of exogenous pulmonary surfactant in the treatment of severe neonatal infectious pneumonia: a multicenter prospective clinical trial

  • QIU Ru-Xin1, LIU Xin2, WANG Jia-Li3, CAI Cheng4, ZENG Jun-An5, LIU Han-Chu2, CHENG Rui3, LI Zhan-Kui5, LIU Jing1
Author information +
文章历史 +

摘要

目的 研究国产外源性肺表面活性物质(珂立苏)对新生儿重症感染性肺炎的治疗效果。方法 研究对象为来自中国5家医院的208例重症感染性肺炎新生儿,在入院时根据家长意愿给予常规治疗(对照组,81例)和珂立苏治疗+常规治疗(珂立苏组,127例),比较两组患儿入院时对氧的依赖程度、治疗前后动脉血气分析结果及肺脏超声表现的变化、机械通气时间、住院时间、住院费用、并发症及预后等。结果 入院时珂立苏组吸入氧浓度明显高于对照组,动脉血氧分压明显低于对照组,二氧化碳分压明显高于对照组,氧合指数明显低于对照组(P < 0.01)。治疗1 h后,两组患儿动脉血气和氧合状态均得到改善,且珂立苏组改善状况显著优于对照组(P < 0.05)。补充珂立苏后4~6 h,患儿肺部实变程度显著减轻。与对照组比较,珂立苏组机械通气时间、住院时间均明显缩短,而两组患儿并发症发生率差异无统计学意义,预后均良好。结论 珂立苏治疗能显著改善新生儿重症感染性肺炎患儿的氧合状态,减轻肺实变程度,缩短患儿机械通气时间和住院时间,值得临床推广应用。

Abstract

Objective To study the clinical effect of calsurf, a domestic exogenous pulmonary surfactant, in the treatment of severe neonatal infectious pneumonia. Methods A total of 208 neonates with severe infectious pneumonia who hospitalized in 5 hospitals of China were enrolled. According to their parents' wishes on admission, these neonates were administered with conventional treatment (control group; n=81) and calsurf treatment + conventional treatment (calsurf treatment group, n=127). The two groups were compared in terms of the degree of oxygen dependence on admission, blood gas parameters before and after treatment, lung ultrasound results, duration of mechanical ventilation, length of hospital stay, hospital costs, complications and prognosis. Results Compared with the control group on admission, the calsurf treatment group had significantly higher inhaled oxygen concentration and partial pressure of carbon dioxide and significantly lower arterial partial pressure of oxygen and oxygenation index (P < 0.01). After 1 hour of treatment, both groups had significant improvements in the above indices (P < 0.05), and the improvements were more significant in the calsurf treatment group (P < 0.05). After 4-6 hours of calsurf administration, there was a significant reduction in the degree of pulmonary consolidation. The calsurf treatment group had significantly shorter duration of mechanical ventilation and length of hospital stay than the control group, while there was no significant difference in the incidence rate of complications between the two groups. The neonates of both groups had a good prognosis. Conclusions In neonates with severe infectious pneumonia, calsurf treatment can significantly improve oxygenation, reduce the degree of pulmonary consolidation, and shorten the duration of mechanical ventilation and length of hospital stay. Therefore, it should be considered in neonates with severe infectious pneumonia.

关键词

感染性肺炎 / 肺表面活性物质 / 珂立苏 / 多中心研究 / 新生儿

Key words

Infectious pneumonia / Pulmonary surfactant / Calsurf / Multicenter trial / Neonate

引用本文

导出引用
邱如新, 刘欣, 王加莉, 蔡成, 曾军安, 刘汉楚, 程锐, 李占魁, 刘敬. 国产外源性肺表面活性物质治疗新生儿重症感染性肺炎多中心前瞻性临床研究[J]. 中国当代儿科杂志. 2019, 21(4): 327-331 https://doi.org/10.7499/j.issn.1008-8830.2019.04.005
QIU Ru-Xin, LIU Xin, WANG Jia-Li, CAI Cheng, ZENG Jun-An, LIU Han-Chu, CHENG Rui, LI Zhan-Kui, LIU Jing. Clinical effect of exogenous pulmonary surfactant in the treatment of severe neonatal infectious pneumonia: a multicenter prospective clinical trial[J]. Chinese Journal of Contemporary Pediatrics. 2019, 21(4): 327-331 https://doi.org/10.7499/j.issn.1008-8830.2019.04.005

参考文献

[1] Sweet DG, Camielli V, Greisen G, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome -2016 Update[J]. Neonatology, 2017, 111(2):107-125.
[2] Walsh BK, Daigle B, DiBlasi RM, et al. AARC Clinical Practice Guideline. Surfactant replacement therapy:2013[J]. Respir Care, 2013, 58(2):367-375.
[3] Polin RA, Carlo WA, Committee on Fetus and Newborn, et al. Surfactant replacement therapy for preterm and term neonates with respiratory distress[J]. Pediatrics, 2014, 133(1):156-163.
[4] 中国医师协会新生儿科医师分会, 《中华围产医学杂志》编辑委员会. 早产儿呼吸窘迫综合征早期防治专家共识[J]. 中华围产医学杂志, 2017, 20(8):557-559.
[5] 董声焕, 孙眉月, 寇同欣,等. 肺表面活性剂(珂立苏)治疗新生儿呼吸窘迫综合征多中心临床试验[J]. 中国小儿急救医学, 2009, 16(2):120-124.
[6] 李文斌, 夏世文, 王琳, 等. 注射用牛肺表面活性物质防治新生儿呼吸窘迫综合征多中心调查[J]. 中华实用儿科临床杂志, 2013, 28(14):1061-1064.
[7] 石云, 杨娜, 刘敬, 等. 国产肺表面活性物质珂立苏治疗足月新生儿呼吸窘迫综合征临床疗效评价[J]. 中国现代医药杂志, 2011, 13(6):9-12.
[8] 刘敬, 李静雅, 韩涛, 等. 珂立苏治疗足月新生儿呼吸窘迫综合征临床研究[J]. 中国小儿急救医学, 2014, 21(5):259-262.
[9] 刘晓梅. 肺表面活性物质在新生儿重症肺炎治疗中的应用[J]. 中国卫生标准管理, 2017, 8(24):47-48.
[10] 马丽娜. 肺表面活性物质在新生儿重症肺炎治疗中的应用价值[J]. 航空航天医学杂志, 2017, 28(5):553-555.
[11] 郭艳梅, 刘翠青. 河北省儿童医院新生儿呼吸衰竭的临床流行病学特点[J]. 中华围产医学杂志, 2012, 15(11):670-675.
[12] 饶懿. 7970例新生儿住院病例分析[J]. 中国病案, 2012, 13(5):71-73.
[13] 赵鸿, 金真菊. 1509例新生儿死亡因素分析[J]. 中国妇幼健康研究, 2009, 20(6):686-688.
[14] Facco M, Nespeca M, Simonato M, et al. In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infants[J]. PLoS One, 2014, 9(12):e93612.
[15] 李熙鸿. 儿童重症肺炎诊断标准的优缺点[J]. 中华实用儿科临床杂志, 2017, 32(6):408-411.
[16] 肖甜甜, 金梅, 巨容,等. 床旁肺部超声在新生儿肺炎中的诊断价值[J]. 中国当代儿科杂志, 2018, 20(6):444-448.
[17] Liu J, Liu F, Liu Y, et al. Lung ultrasonography for the diagnosis of severe neonatal pneumonia[J]. Chest, 2014, 146(2):383-388.

基金

吴阶平医学基金会临床科研专项资助项目[320.6750.16092]。


PDF(1394 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/